Publications by the researcher in collaboration with Alfonso Jesús Domínguez-Gil Hurlé (13)

2002

  1. Amiodarone-induced skin pigmentation and pulmonary fibrosis

    Hospital Pharmacy, Vol. 37, Núm. 6, pp. 615-618

1996

  1. Application of population pharmacokinetics to the optimization of theophylline therapy

    Journal of Clinical Pharmacy and Therapeutics, Vol. 21, Núm. 2, pp. 113-125

1994

  1. SEGUIMIENTO DEL TRATAMIENTO ANTITUBERCULOSO

    Revista Clinica Espanola, Vol. 194, Núm. 9, pp. 677-685

1991

  1. Bioequivalence of a new formulation of flecainide acetate.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 216-220

1987

  1. Determination of plasma theophylline levels using a new analytical technique

    Farmacia Clinica, Vol. 4, Núm. 7 (528-530)+, pp. 532

  2. Efficacy of maintenance of therapeutic serum concentrations of theophylline in chronic asthma

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 25, Núm. 3, pp. 157-162

  3. Incumplimiento terapéutico en enfermos con obstrucción crónica al flujo aéreo.

    Revista Clinica Espanola, Vol. 180, Núm. 6, pp. 293-295

1986

  1. Pleural fluid levels of cefoxitin in patients with renal impairment

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 24, Núm. 9, pp. 485-489

1984

  1. FARMACOCINETICA DE CEFMETAZOL Y CEFOXITINA TRAS SU ADMINISTRACION SIMULTANEA A VOLUNTARIOS SANOS

    Revista de Farmacologia Clinica y Experimental, Vol. 1, Núm. 2, pp. 121-124

  2. Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion

    European Journal of Clinical Pharmacology, Vol. 26, Núm. 3, pp. 389-392

  3. Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 22, Núm. 6, pp. 300-303

1981

  1. Disposition of cefoxitin in patients with pleural effusion

    Clinical Therapeutics, Vol. 3, Núm. 6, pp. 425-435